

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | protein neddylation (GO:0045116) | 6.59115776 |
| 2 | thrombin receptor signaling pathway (GO:0070493) | 6.31165078 |
| 3 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 5.47072497 |
| 4 | regulation of platelet aggregation (GO:0090330) | 5.19292719 |
| 5 | regulation of platelet activation (GO:0010543) | 4.96440808 |
| 6 | extracellular fibril organization (GO:0043206) | 4.94105749 |
| 7 | neutrophil activation involved in immune response (GO:0002283) | 4.57668731 |
| 8 | negative regulation of homotypic cell-cell adhesion (GO:0034111) | 4.49831952 |
| 9 | endothelium development (GO:0003158) | 4.22607724 |
| 10 | negative regulation of platelet activation (GO:0010544) | 4.11496601 |
| 11 | platelet degranulation (GO:0002576) | 4.05003505 |
| 12 | blood coagulation, intrinsic pathway (GO:0007597) | 3.83504785 |
| 13 | regulation of homotypic cell-cell adhesion (GO:0034110) | 3.71410879 |
| 14 | positive regulation of endothelial cell differentiation (GO:0045603) | 3.71155535 |
| 15 | homotypic cell-cell adhesion (GO:0034109) | 3.70741751 |
| 16 | negative regulation of thymocyte apoptotic process (GO:0070244) | 3.70594990 |
| 17 | regulation of integrin activation (GO:0033623) | 3.70303209 |
| 18 | lipoxygenase pathway (GO:0019372) | 3.61249429 |
| 19 | adenosine receptor signaling pathway (GO:0001973) | 3.51821399 |
| 20 | positive regulation of mitochondrial calcium ion concentration (GO:0051561) | 3.49824217 |
| 21 | negative regulation of macrophage derived foam cell differentiation (GO:0010745) | 3.44476795 |
| 22 | ribosomal small subunit assembly (GO:0000028) | 3.43233992 |
| 23 | Arp2/3 complex-mediated actin nucleation (GO:0034314) | 3.41281522 |
| 24 | negative regulation of ryanodine-sensitive calcium-release channel activity (GO:0060315) | 3.38582160 |
| 25 | negative regulation of phagocytosis (GO:0050765) | 3.38333530 |
| 26 | negative regulation of stress fiber assembly (GO:0051497) | 3.36712934 |
| 27 | positive regulation of mast cell activation (GO:0033005) | 3.30773432 |
| 28 | megakaryocyte development (GO:0035855) | 3.27993192 |
| 29 | sequestering of actin monomers (GO:0042989) | 3.27818377 |
| 30 | phagocytosis, engulfment (GO:0006911) | 3.27364471 |
| 31 | G-protein coupled purinergic nucleotide receptor signaling pathway (GO:0035589) | 3.22259127 |
| 32 | positive regulation of blood coagulation (GO:0030194) | 3.19720916 |
| 33 | positive regulation of hemostasis (GO:1900048) | 3.19720916 |
| 34 | autophagic vacuole fusion (GO:0000046) | 3.18739856 |
| 35 | platelet activation (GO:0030168) | 3.17899827 |
| 36 | positive regulation of Rho protein signal transduction (GO:0035025) | 3.14280434 |
| 37 | response to interferon-alpha (GO:0035455) | 3.12689021 |
| 38 | positive regulation of receptor recycling (GO:0001921) | 3.10002198 |
| 39 | regulation of Golgi to plasma membrane protein transport (GO:0042996) | 3.09076513 |
| 40 | response to peptidoglycan (GO:0032494) | 3.08119235 |
| 41 | positive regulation of natural killer cell differentiation (GO:0032825) | 3.06989114 |
| 42 | wound healing, spreading of epidermal cells (GO:0035313) | 3.05803526 |
| 43 | deoxyribonucleoside monophosphate metabolic process (GO:0009162) | 3.05108406 |
| 44 | negative regulation of protein localization to plasma membrane (GO:1903077) | 3.02557465 |
| 45 | respiratory burst (GO:0045730) | 3.01843499 |
| 46 | regulation of T-helper 1 cell differentiation (GO:0045625) | 3.01404878 |
| 47 | positive regulation of macrophage differentiation (GO:0045651) | 2.96929062 |
| 48 | positive regulation of interferon-alpha production (GO:0032727) | 2.96751806 |
| 49 | fusion of sperm to egg plasma membrane (GO:0007342) | 2.96040556 |
| 50 | neutrophil activation (GO:0042119) | 2.93250557 |
| 51 | negative regulation of protein localization to cell surface (GO:2000009) | 2.92212686 |
| 52 | negative regulation of T cell apoptotic process (GO:0070233) | 2.91596138 |
| 53 | negative regulation of norepinephrine secretion (GO:0010700) | 2.88602389 |
| 54 | cyclooxygenase pathway (GO:0019371) | 2.88352495 |
| 55 | positive regulation by symbiont of host defense response (GO:0052509) | 2.87660168 |
| 56 | modulation by symbiont of host defense response (GO:0052031) | 2.87660168 |
| 57 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 2.87660168 |
| 58 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 2.87660168 |
| 59 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 2.87660168 |
| 60 | modulation by symbiont of host immune response (GO:0052553) | 2.87660168 |
| 61 | mesodermal cell differentiation (GO:0048333) | 2.87362605 |
| 62 | negative regulation of smooth muscle cell migration (GO:0014912) | 2.86741518 |
| 63 | definitive hemopoiesis (GO:0060216) | 2.86065131 |
| 64 | positive regulation of coagulation (GO:0050820) | 2.85210460 |
| 65 | immunoglobulin mediated immune response (GO:0016064) | 2.84875566 |
| 66 | negative regulation of heart rate (GO:0010459) | 2.83573286 |
| 67 | production of molecular mediator involved in inflammatory response (GO:0002532) | 2.83115036 |
| 68 | response to interferon-beta (GO:0035456) | 2.82421404 |
| 69 | regulation of macrophage derived foam cell differentiation (GO:0010743) | 2.77415542 |
| 70 | regulation of metalloenzyme activity (GO:0048552) | 2.77164123 |
| 71 | regulation of interferon-alpha production (GO:0032647) | 2.76439666 |
| 72 | positive regulation of tumor necrosis factor biosynthetic process (GO:0042535) | 2.76153557 |
| 73 | positive regulation of syncytium formation by plasma membrane fusion (GO:0060143) | 2.74994549 |
| 74 | negative regulation of neural precursor cell proliferation (GO:2000178) | 2.74982904 |
| 75 | regulation of syncytium formation by plasma membrane fusion (GO:0060142) | 2.73934438 |
| 76 | mitochondrial calcium ion transport (GO:0006851) | 2.73558829 |
| 77 | granulocyte activation (GO:0036230) | 2.73392733 |
| 78 | membrane raft organization (GO:0031579) | 2.73356547 |
| 79 | leukocyte degranulation (GO:0043299) | 2.72636692 |
| 80 | negative regulation of T-helper cell differentiation (GO:0045623) | 2.71104443 |
| 81 | negative regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043371) | 2.71104443 |
| 82 | regulation of blood coagulation (GO:0030193) | 2.71040509 |
| 83 | regulation of hemostasis (GO:1900046) | 2.71040509 |
| 84 | platelet formation (GO:0030220) | 2.70109063 |
| 85 | actin nucleation (GO:0045010) | 2.69881380 |
| 86 | negative regulation of mast cell activation (GO:0033004) | 2.68967095 |
| 87 | wound healing, spreading of cells (GO:0044319) | 2.67904108 |
| 88 | regulation of interferon-beta biosynthetic process (GO:0045357) | 2.64892892 |
| 89 | positive regulation of lamellipodium assembly (GO:0010592) | 2.64395603 |
| 90 | purinergic nucleotide receptor signaling pathway (GO:0035590) | 2.63676824 |
| 91 | pinocytosis (GO:0006907) | 2.63520395 |
| 92 | polyamine biosynthetic process (GO:0006596) | 2.63408788 |
| 93 | intrinsic apoptotic signaling pathway in response to oxidative stress (GO:0008631) | 2.63181862 |
| 94 | regulation of receptor recycling (GO:0001919) | 2.60730006 |
| 95 | organelle membrane fusion (GO:0090174) | 2.60729169 |
| 96 | protein maturation by protein folding (GO:0022417) | 2.59215025 |
| 97 | detection of molecule of bacterial origin (GO:0032490) | 2.58985134 |
| 98 | B cell mediated immunity (GO:0019724) | 2.58637744 |
| 99 | pyrimidine deoxyribonucleotide metabolic process (GO:0009219) | 2.58402801 |
| 100 | membrane invagination (GO:0010324) | 2.57912587 |
| 101 | purine-containing compound salvage (GO:0043101) | 2.56955685 |
| 102 | regulation of endothelial cell differentiation (GO:0045601) | 2.56655964 |
| 103 | regulation of coagulation (GO:0050818) | 2.55649423 |
| 104 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 2.53673468 |
| 105 | regulation of protein heterodimerization activity (GO:0043497) | 2.51563708 |
| 106 | regulation of chemokine biosynthetic process (GO:0045073) | 2.51391546 |
| 107 | negative regulation of CD4-positive, alpha-beta T cell activation (GO:2000515) | 2.50584239 |
| 108 | adenosine metabolic process (GO:0046085) | 2.49920149 |
| 109 | platelet aggregation (GO:0070527) | 2.49868676 |
| 110 | regulation of mast cell activation (GO:0033003) | 2.49657830 |
| 111 | positive regulation of endothelial cell apoptotic process (GO:2000353) | 2.48832263 |
| 112 | muscle cell migration (GO:0014812) | 2.48618184 |
| 113 | fibril organization (GO:0097435) | 2.48095858 |
| 114 | hypotonic response (GO:0006971) | 2.46567187 |
| 115 | platelet dense granule organization (GO:0060155) | 2.46374349 |
| 116 | negative regulation of nitric-oxide synthase activity (GO:0051001) | 2.45969068 |
| 117 | positive regulation of B cell differentiation (GO:0045579) | 2.45959549 |
| 118 | positive regulation of substrate adhesion-dependent cell spreading (GO:1900026) | 2.45606612 |
| 119 | positive regulation of interleukin-8 secretion (GO:2000484) | 2.45565413 |
| 120 | positive regulation of granulocyte differentiation (GO:0030854) | 2.45559445 |
| 121 | activation of transmembrane receptor protein tyrosine kinase activity (GO:0007171) | 2.44229249 |
| 122 | regulation of lipoprotein metabolic process (GO:0050746) | 2.44207898 |
| 123 | regulation of macrophage differentiation (GO:0045649) | 2.44028796 |
| 124 | G-protein coupled purinergic receptor signaling pathway (GO:0035588) | 2.43246922 |
| 125 | pyrimidine nucleoside catabolic process (GO:0046135) | 2.43151568 |
| 126 | peptide catabolic process (GO:0043171) | 2.43121646 |
| 127 | superoxide anion generation (GO:0042554) | 2.42762878 |
| 128 | positive regulation of systemic arterial blood pressure (GO:0003084) | 2.41278636 |
| 129 | regulation of B cell receptor signaling pathway (GO:0050855) | 2.40354958 |
| 130 | regulation of integrin-mediated signaling pathway (GO:2001044) | 2.39310196 |
| 131 | chondrocyte proliferation (GO:0035988) | 2.37792462 |
| 132 | cell adhesion mediated by integrin (GO:0033627) | 2.37221017 |
| 133 | positive regulation of chemokine biosynthetic process (GO:0045080) | 2.36795180 |
| 134 | viral transcription (GO:0019083) | 2.36438555 |
| 135 | cellular extravasation (GO:0045123) | 2.34740305 |
| 136 | positive regulation of monocyte chemotaxis (GO:0090026) | 2.34460094 |
| 137 | angiogenesis involved in wound healing (GO:0060055) | 2.34008695 |
| 138 | signal peptide processing (GO:0006465) | 2.33635742 |
| 139 | regulation of necroptotic process (GO:0060544) | 2.32991051 |
| 140 | regulation of monocyte chemotaxis (GO:0090025) | 2.32928502 |
| 141 | regulation of interleukin-8 secretion (GO:2000482) | 2.32111445 |
| 142 | positive regulation of interleukin-8 biosynthetic process (GO:0045416) | 2.30960288 |
| 143 | endosome to pigment granule transport (GO:0043485) | 2.30778732 |
| 144 | endosome to melanosome transport (GO:0035646) | 2.30778732 |
| 145 | SRP-dependent cotranslational protein targeting to membrane (GO:0006614) | 2.30442905 |
| 146 | endodermal cell differentiation (GO:0035987) | 2.30334164 |
| 147 | regulation of T cell migration (GO:2000404) | 2.29190462 |
| 148 | antigen processing and presentation of exogenous peptide antigen via MHC class I (GO:0042590) | 2.28569893 |
| 149 | T cell apoptotic process (GO:0070231) | 2.28337406 |
| 150 | translational termination (GO:0006415) | 2.27969117 |
| 151 | regulation of mast cell activation involved in immune response (GO:0033006) | 2.27777935 |
| 152 | regulation of natural killer cell differentiation (GO:0032823) | 2.25720401 |
| 153 | myeloid cell homeostasis (GO:0002262) | 2.25596353 |
| 154 | barbed-end actin filament capping (GO:0051016) | 2.24831926 |
| 155 | regulation of mast cell degranulation (GO:0043304) | 2.24374204 |
| 156 | leukocyte aggregation (GO:0070486) | 2.23701168 |
| 157 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 2.23552220 |
| 158 | cotranslational protein targeting to membrane (GO:0006613) | 2.22299167 |
| 159 | response to muramyl dipeptide (GO:0032495) | 2.22166329 |
| 160 | myeloid cell activation involved in immune response (GO:0002275) | 2.21933253 |
| 161 | protein targeting to ER (GO:0045047) | 2.21690754 |
| 162 | myeloid dendritic cell activation (GO:0001773) | 2.20556722 |
| 163 | cellular response to interferon-beta (GO:0035458) | 2.20229190 |
| 164 | regulation of mononuclear cell migration (GO:0071675) | 2.20104179 |
| 165 | positive regulation of tumor necrosis factor superfamily cytokine production (GO:1903557) | 2.19909875 |
| 166 | negative regulation of myeloid cell apoptotic process (GO:0033033) | 2.19872282 |
| 167 | leukocyte migration involved in inflammatory response (GO:0002523) | 2.18031055 |
| 168 | cellular response to interferon-alpha (GO:0035457) | 2.18001209 |
| 169 | regulation of lymphocyte migration (GO:2000401) | 2.17971878 |
| 170 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 2.17692779 |
| 171 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 2.17692779 |
| 172 | vascular endothelial growth factor signaling pathway (GO:0038084) | 2.16466300 |
| 173 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 2.16059136 |
| 174 | negative regulation of nitric oxide biosynthetic process (GO:0045019) | 2.15597027 |
| 175 | regulation of macrophage cytokine production (GO:0010935) | 2.14503558 |
| 176 | positive regulation of gamma-delta T cell activation (GO:0046645) | 2.14063374 |
| 177 | positive regulation of tumor necrosis factor production (GO:0032760) | 2.13941766 |
| 178 | macrophage activation involved in immune response (GO:0002281) | 2.13327740 |
| 179 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent (GO: | 2.12369328 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 5.08497016 |
| 2 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 4.16864415 |
| 3 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 4.06177287 |
| 4 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 3.46766035 |
| 5 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 3.17381875 |
| 6 | * MYB_21317192_ChIP-Seq_ERMYB_Mouse | 3.07497765 |
| 7 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 3.05970663 |
| 8 | * MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 3.00664037 |
| 9 | E2F7_22180533_ChIP-Seq_HELA_Human | 2.89666556 |
| 10 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 2.88576445 |
| 11 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 2.57252159 |
| 12 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.49689640 |
| 13 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 2.49478839 |
| 14 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 2.49290060 |
| 15 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.49143922 |
| 16 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 2.45279331 |
| 17 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 2.37210088 |
| 18 | * SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 2.31437879 |
| 19 | SPI1_23547873_ChIP-Seq_NB4_Human | 2.23954555 |
| 20 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 2.22238749 |
| 21 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 2.14530785 |
| 22 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 2.12672598 |
| 23 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 2.11030862 |
| 24 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 2.09297508 |
| 25 | SCL_19346495_ChIP-Seq_HPC-7_Human | 2.09274608 |
| 26 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 2.06635136 |
| 27 | GATA1_19941826_ChIP-Seq_K562_Human | 2.03170204 |
| 28 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 2.02890900 |
| 29 | * GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.99515050 |
| 30 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.98838602 |
| 31 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.94307442 |
| 32 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.94025647 |
| 33 | ELK1_19687146_ChIP-ChIP_HELA_Human | 1.93411863 |
| 34 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.88126889 |
| 35 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.77696492 |
| 36 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 1.74735949 |
| 37 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 1.72155172 |
| 38 | GATA2_19941826_ChIP-Seq_K562_Human | 1.71690416 |
| 39 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.70092483 |
| 40 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 1.69088776 |
| 41 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.68678256 |
| 42 | CEBPD_21427703_ChIP-Seq_3T3-L1_Mouse | 1.66980243 |
| 43 | JUND_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.66164593 |
| 44 | * MYC_18555785_ChIP-Seq_MESCs_Mouse | 1.64956136 |
| 45 | * BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.64495068 |
| 46 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.61127654 |
| 47 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.60564714 |
| 48 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 1.58970146 |
| 49 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 1.57205141 |
| 50 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.55245575 |
| 51 | JUN_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.54823709 |
| 52 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.54603291 |
| 53 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 1.54294589 |
| 54 | * TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.54143754 |
| 55 | CHD7_19251738_ChIP-ChIP_MESCs_Mouse | 1.53881315 |
| 56 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.53006245 |
| 57 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 1.52167548 |
| 58 | MYB_26560356_Chip-Seq_TH2_Human | 1.51526181 |
| 59 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.47876640 |
| 60 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.44973646 |
| 61 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 1.43831304 |
| 62 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.42953940 |
| 63 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.41288753 |
| 64 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 1.40153495 |
| 65 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.39024089 |
| 66 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 1.37796823 |
| 67 | ATF3_23680149_ChIP-Seq_GBM1-GSC_Human | 1.37643244 |
| 68 | ERG_20887958_ChIP-Seq_HPC-7_Mouse | 1.35630020 |
| 69 | * SRF_21415370_ChIP-Seq_HL-1_Mouse | 1.31604567 |
| 70 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.30894822 |
| 71 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.30125420 |
| 72 | EST1_17652178_ChIP-ChIP_JURKAT_Human | 1.29764300 |
| 73 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 1.28937040 |
| 74 | PU_27001747_Chip-Seq_BMDM_Mouse | 1.28347431 |
| 75 | HSF1_23293686_ChIP-Seq_STHDH_STRIATAL_Mouse | 1.28143545 |
| 76 | HTT_18923047_ChIP-ChIP_STHdh_Human | 1.26098745 |
| 77 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.25032192 |
| 78 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.24705933 |
| 79 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.22803264 |
| 80 | GATA1_22025678_ChIP-Seq_K562_Human | 1.22511945 |
| 81 | SMAD3_18955504_ChIP-ChIP_HaCaT_Human | 1.22030321 |
| 82 | SMAD2_18955504_ChIP-ChIP_HaCaT_Human | 1.22030321 |
| 83 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.21659361 |
| 84 | TFEB_21752829_ChIP-Seq_HELA_Human | 1.21176774 |
| 85 | MYB_26560356_Chip-Seq_TH1_Human | 1.20994211 |
| 86 | MAF_26560356_Chip-Seq_TH1_Human | 1.19703781 |
| 87 | SPI1_23127762_ChIP-Seq_K562_Human | 1.19694528 |
| 88 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 1.19543261 |
| 89 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.19471260 |
| 90 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 1.19306401 |
| 91 | SALL4_22934838_ChIP-ChIP_CD34+_Human | 1.18948138 |
| 92 | CJUN_26792858_Chip-Seq_BT549_Human | 1.18004388 |
| 93 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.17153484 |
| 94 | PPARD_23208498_ChIP-Seq_MDA-MB-231_Human | 1.16226199 |
| 95 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.15749104 |
| 96 | GFI1B_20887958_ChIP-Seq_HPC-7_Mouse | 1.15453013 |
| 97 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.14995771 |
| 98 | BRD4_25478319_ChIP-Seq_HGPS_Human | 1.13919809 |
| 99 | * ELK1_22589737_ChIP-Seq_MCF10A_Human | 1.13721095 |
| 100 | * CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.13561443 |
| 101 | NELFA_20434984_ChIP-Seq_ESCs_Mouse | 1.13424711 |
| 102 | FOXM1_25889361_ChIP-Seq_OE33_AND_U2OS_Human | 1.11910451 |
| 103 | WT1_19549856_ChIP-ChIP_CCG9911_Human | 1.11539622 |
| 104 | RBPJ_22232070_ChIP-Seq_NCS_Mouse | 1.11215415 |
| 105 | GATA3_26560356_Chip-Seq_TH2_Human | 1.10461815 |
| 106 | E2F1_18555785_ChIP-Seq_MESCs_Mouse | 1.09817555 |
| 107 | CEBPB_24764292_ChIP-Seq_MC3T3_Mouse | 1.09718157 |
| 108 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 1.08915143 |
| 109 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 1.08547741 |
| 110 | * FOXO3_22982991_ChIP-Seq_MACROPHAGES_Mouse | 1.08049823 |
| 111 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.07863041 |
| 112 | HOXA2_22223247_ChIP-Seq_E11.5_EMBRYO_Mouse | 1.06004008 |
| 113 | NKX2-5_21415370_ChIP-Seq_HL-1_Mouse | 1.05101735 |
| 114 | VDR_21846776_ChIP-Seq_THP-1_Human | 1.05027275 |
| 115 | SOX2_20726797_ChIP-Seq_SW620_Human | 1.04405264 |
| 116 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 1.04186603 |
| 117 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.03825603 |
| 118 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.02970488 |
| 119 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 1.02268072 |
| 120 | * CUX1_19635798_ChIP-ChIP_MULTIPLE_HUMAN_CANCER_TYPES_Human | 1.02264008 |
| 121 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.01267813 |
| 122 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.01209506 |
| 123 | * MYC_18358816_ChIP-ChIP_MESCs_Mouse | 1.00761529 |
| 124 | DCP1A_22483619_ChIP-Seq_HELA_Human | 0.99745383 |
| 125 | GATA3_27048872_Chip-Seq_THYMUS_Human | 0.99256921 |
| 126 | E2F4_17652178_ChIP-ChIP_JURKAT_Human | 0.98906424 |
| 127 | CREB1_15753290_ChIP-ChIP_HEK293T_Human | 0.98245790 |
| 128 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 0.98077978 |
| 129 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 0.98074222 |
| 130 | GATA1_19941827_ChIP-Seq_MEL86_Mouse | 0.96322459 |
| 131 | * FLI1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.95091256 |
| 132 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 0.94732399 |
| 133 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.94210461 |
| 134 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 0.93610739 |
| 135 | * CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.91863187 |
| 136 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 0.91061522 |
| 137 | * CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.88613264 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0008438_abnormal_cutaneous_collagen | 4.06478351 |
| 2 | MP0008004_abnormal_stomach_pH | 3.48555549 |
| 3 | MP0003279_aneurysm | 3.03014009 |
| 4 | MP0001835_abnormal_antigen_presentation | 2.78509556 |
| 5 | MP0003724_increased_susceptibility_to | 2.66822697 |
| 6 | MP0005503_abnormal_tendon_morphology | 2.47666262 |
| 7 | MP0006054_spinal_hemorrhage | 2.43703091 |
| 8 | MP0003436_decreased_susceptibility_to | 2.37775771 |
| 9 | MP0009785_altered_susceptibility_to | 2.35088858 |
| 10 | MP0002396_abnormal_hematopoietic_system | 2.30681181 |
| 11 | MP0002148_abnormal_hypersensitivity_rea | 2.22134338 |
| 12 | MP0002419_abnormal_innate_immunity | 2.17545923 |
| 13 | MP0001958_emphysema | 2.16959161 |
| 14 | MP0000343_altered_response_to | 2.05688100 |
| 15 | MP0005275_abnormal_skin_tensile | 1.84498149 |
| 16 | MP0001533_abnormal_skeleton_physiology | 1.84174850 |
| 17 | MP0004084_abnormal_cardiac_muscle | 1.84135998 |
| 18 | MP0000685_abnormal_immune_system | 1.82746914 |
| 19 | MP0005000_abnormal_immune_tolerance | 1.82185713 |
| 20 | MP0005025_abnormal_response_to | 1.78229988 |
| 21 | MP0000858_altered_metastatic_potential | 1.77623376 |
| 22 | MP0003566_abnormal_cell_adhesion | 1.77533947 |
| 23 | MP0002452_abnormal_antigen_presenting | 1.74332992 |
| 24 | MP0005464_abnormal_platelet_physiology | 1.73109569 |
| 25 | MP0001853_heart_inflammation | 1.72526642 |
| 26 | MP0004808_abnormal_hematopoietic_stem | 1.71595545 |
| 27 | MP0005671_abnormal_response_to | 1.69271125 |
| 28 | MP0001879_abnormal_lymphatic_vessel | 1.65546536 |
| 29 | MP0004272_abnormal_basement_membrane | 1.63257488 |
| 30 | MP0010368_abnormal_lymphatic_system | 1.62406225 |
| 31 | MP0005397_hematopoietic_system_phenotyp | 1.61723822 |
| 32 | MP0001545_abnormal_hematopoietic_system | 1.61723822 |
| 33 | MP0002166_altered_tumor_susceptibility | 1.56864705 |
| 34 | MP0002405_respiratory_system_inflammati | 1.55609027 |
| 35 | MP0005023_abnormal_wound_healing | 1.55490062 |
| 36 | MP0003186_abnormal_redox_activity | 1.53341736 |
| 37 | MP0001790_abnormal_immune_system | 1.50298425 |
| 38 | MP0005387_immune_system_phenotype | 1.50298425 |
| 39 | MP0001819_abnormal_immune_cell | 1.48607648 |
| 40 | MP0003303_peritoneal_inflammation | 1.48448828 |
| 41 | MP0003828_pulmonary_edema | 1.48434133 |
| 42 | MP0002420_abnormal_adaptive_immunity | 1.48153524 |
| 43 | MP0009384_cardiac_valve_regurgitation | 1.47501260 |
| 44 | MP0002723_abnormal_immune_serum | 1.47091460 |
| 45 | MP0003448_altered_tumor_morphology | 1.45113177 |
| 46 | MP0001800_abnormal_humoral_immune | 1.44456291 |
| 47 | MP0006082_CNS_inflammation | 1.43957790 |
| 48 | MP0005058_abnormal_lysosome_morphology | 1.43450676 |
| 49 | MP0002006_tumorigenesis | 1.40601590 |
| 50 | MP0000230_abnormal_systemic_arterial | 1.39210986 |
| 51 | MP0005390_skeleton_phenotype | 1.38674828 |
| 52 | MP0000767_abnormal_smooth_muscle | 1.37684463 |
| 53 | MP0008775_abnormal_heart_ventricle | 1.36788050 |
| 54 | MP0002933_joint_inflammation | 1.35894046 |
| 55 | MP0001542_abnormal_bone_strength | 1.34682861 |
| 56 | MP0003806_abnormal_nucleotide_metabolis | 1.33659544 |
| 57 | MP0005164_abnormal_response_to | 1.31271253 |
| 58 | MP0005083_abnormal_biliary_tract | 1.30023270 |
| 59 | MP0010352_gastrointestinal_tract_polyps | 1.29193456 |
| 60 | MP0000465_gastrointestinal_hemorrhage | 1.26882213 |
| 61 | MP0009333_abnormal_splenocyte_physiolog | 1.24580054 |
| 62 | MP0009763_increased_sensitivity_to | 1.23734082 |
| 63 | MP0009278_abnormal_bone_marrow | 1.23157504 |
| 64 | MP0002398_abnormal_bone_marrow | 1.20308765 |
| 65 | MP0000490_abnormal_crypts_of | 1.18952275 |
| 66 | MP0004036_abnormal_muscle_relaxation | 1.18950131 |
| 67 | MP0003091_abnormal_cell_migration | 1.17052484 |
| 68 | MP0009697_abnormal_copulation | 1.14773552 |
| 69 | MP0002998_abnormal_bone_remodeling | 1.13848190 |
| 70 | MP0002132_abnormal_respiratory_system | 1.13428252 |
| 71 | MP0000716_abnormal_immune_system | 1.13091051 |
| 72 | MP0001845_abnormal_inflammatory_respons | 1.12352998 |
| 73 | MP0008007_abnormal_cellular_replicative | 1.11760370 |
| 74 | MP0004883_abnormal_blood_vessel | 1.07290122 |
| 75 | MP0010155_abnormal_intestine_physiology | 1.07153577 |
| 76 | MP0009764_decreased_sensitivity_to | 1.06189948 |
| 77 | MP0005508_abnormal_skeleton_morphology | 1.05916295 |
| 78 | MP0003705_abnormal_hypodermis_morpholog | 1.05714185 |
| 79 | MP0003950_abnormal_plasma_membrane | 1.05419896 |
| 80 | MP0002429_abnormal_blood_cell | 1.05056167 |
| 81 | MP0000249_abnormal_blood_vessel | 1.04098073 |
| 82 | MP0000689_abnormal_spleen_morphology | 1.03440538 |
| 83 | MP0002722_abnormal_immune_system | 1.01501001 |
| 84 | MP0003183_abnormal_peptide_metabolism | 0.93368156 |
| 85 | MP0002295_abnormal_pulmonary_circulatio | 0.93067744 |
| 86 | MP0001851_eye_inflammation | 0.92709497 |
| 87 | MP0008469_abnormal_protein_level | 0.91611004 |
| 88 | MP0003638_abnormal_response/metabolism_ | 0.90863341 |
| 89 | MP0003300_gastrointestinal_ulcer | 0.90747907 |
| 90 | MP0004947_skin_inflammation | 0.89512313 |
| 91 | MP0005167_abnormal_blood-brain_barrier | 0.89390424 |
| 92 | MP0005410_abnormal_fertilization | 0.88511284 |
| 93 | MP0003795_abnormal_bone_structure | 0.88292102 |
| 94 | MP0003075_altered_response_to | 0.86822834 |
| 95 | MP0004510_myositis | 0.85992341 |
| 96 | MP0001243_abnormal_dermal_layer | 0.84683894 |
| 97 | MP0005257_abnormal_intraocular_pressure | 0.84249669 |
| 98 | MP0003191_abnormal_cellular_cholesterol | 0.83971314 |
| 99 | MP0004134_abnormal_chest_morphology | 0.83680119 |
| 100 | MP0002877_abnormal_melanocyte_morpholog | 0.82701696 |
| 101 | MP0008260_abnormal_autophagy | 0.82686478 |
| 102 | MP0002060_abnormal_skin_morphology | 0.81970645 |
| 103 | MP0005623_abnormal_meninges_morphology | 0.81406590 |
| 104 | MP0003763_abnormal_thymus_physiology | 0.79809783 |
| 105 | MP0005084_abnormal_gallbladder_morpholo | 0.79088466 |
| 106 | MP0009765_abnormal_xenobiotic_induced | 0.78502381 |
| 107 | MP0001915_intracranial_hemorrhage | 0.77654770 |
| 108 | MP0001663_abnormal_digestive_system | 0.77318789 |
| 109 | MP0003866_abnormal_defecation | 0.77187333 |
| 110 | MP0003656_abnormal_erythrocyte_physiolo | 0.77156873 |
| 111 | MP0001614_abnormal_blood_vessel | 0.77109409 |
| 112 | MP0009379_abnormal_foot_pigmentation | 0.76121685 |
| 113 | MP0002128_abnormal_blood_circulation | 0.75561115 |
| 114 | MP0001544_abnormal_cardiovascular_syste | 0.75415320 |
| 115 | MP0005385_cardiovascular_system_phenoty | 0.75415320 |
| 116 | MP0005171_absent_coat_pigmentation | 0.74931973 |
| 117 | MP0005595_abnormal_vascular_smooth | 0.74859556 |
| 118 | MP0003172_abnormal_lysosome_physiology | 0.74326679 |
| 119 | MP0002113_abnormal_skeleton_development | 0.74119248 |
| 120 | MP0000372_irregular_coat_pigmentation | 0.73623509 |
| 121 | MP0005165_increased_susceptibility_to | 0.71065538 |
| 122 | MP0005174_abnormal_tail_pigmentation | 0.71019945 |
| 123 | MP0000733_abnormal_muscle_development | 0.70070337 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Menorrhagia (HP:0000132) | 7.86100075 |
| 2 | Gingival bleeding (HP:0000225) | 5.53161100 |
| 3 | Abnormal platelet function (HP:0011869) | 4.92770058 |
| 4 | Impaired platelet aggregation (HP:0003540) | 4.92770058 |
| 5 | Recurrent abscess formation (HP:0002722) | 4.70915740 |
| 6 | Protrusio acetabuli (HP:0003179) | 4.55073353 |
| 7 | Eczematoid dermatitis (HP:0000976) | 4.05072021 |
| 8 | Premature rupture of membranes (HP:0001788) | 4.01998847 |
| 9 | Recurrent bacterial skin infections (HP:0005406) | 3.96471573 |
| 10 | Vertebral compression fractures (HP:0002953) | 3.86387623 |
| 11 | Aortic aneurysm (HP:0004942) | 3.65536044 |
| 12 | Aortic dissection (HP:0002647) | 3.50562711 |
| 13 | Hyperlipoproteinemia (HP:0010980) | 3.46943888 |
| 14 | Conjunctival telangiectasia (HP:0000524) | 3.44712552 |
| 15 | Elevated erythrocyte sedimentation rate (HP:0003565) | 3.21121736 |
| 16 | Myositis (HP:0100614) | 3.18745092 |
| 17 | Abnormality of the vasculature of the conjunctiva (HP:0008054) | 3.17987251 |
| 18 | Petechiae (HP:0000967) | 3.06958969 |
| 19 | Hepatosplenomegaly (HP:0001433) | 3.00349919 |
| 20 | Vacuolated lymphocytes (HP:0001922) | 2.96489494 |
| 21 | Increased IgM level (HP:0003496) | 2.95366365 |
| 22 | Osteolytic defects of the phalanges of the hand (HP:0009771) | 2.93112708 |
| 23 | Osteolytic defects of the hand bones (HP:0009699) | 2.93112708 |
| 24 | Abnormal pupillary function (HP:0007686) | 2.86967234 |
| 25 | Peritonitis (HP:0002586) | 2.86888402 |
| 26 | Abnormality of macrophages (HP:0004311) | 2.86135707 |
| 27 | Cervical subluxation (HP:0003308) | 2.83214923 |
| 28 | Cellulitis (HP:0100658) | 2.74032735 |
| 29 | Recurrent gram-negative bacterial infections (HP:0005420) | 2.73993163 |
| 30 | Beaking of vertebral bodies (HP:0004568) | 2.72518811 |
| 31 | Abnormality of the heme biosynthetic pathway (HP:0010472) | 2.69027070 |
| 32 | Biconcave vertebral bodies (HP:0004586) | 2.66804874 |
| 33 | Soft skin (HP:0000977) | 2.66314826 |
| 34 | Dyschromatopsia (HP:0007641) | 2.63195397 |
| 35 | Thrombocytosis (HP:0001894) | 2.62089383 |
| 36 | Autoimmune hemolytic anemia (HP:0001890) | 2.62052734 |
| 37 | Spondylolisthesis (HP:0003302) | 2.55819595 |
| 38 | Stomatitis (HP:0010280) | 2.48420324 |
| 39 | Orchitis (HP:0100796) | 2.47411217 |
| 40 | Abnormality of the common coagulation pathway (HP:0010990) | 2.46041058 |
| 41 | Poikilocytosis (HP:0004447) | 2.44437139 |
| 42 | Paralysis (HP:0003470) | 2.43988153 |
| 43 | Recurrent skin infections (HP:0001581) | 2.42257792 |
| 44 | Syringomyelia (HP:0003396) | 2.42169689 |
| 45 | Spinal cord lesions (HP:0100561) | 2.42169689 |
| 46 | Mediastinal lymphadenopathy (HP:0100721) | 2.39053352 |
| 47 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 2.37314407 |
| 48 | Follicular hyperkeratosis (HP:0007502) | 2.36461630 |
| 49 | Dilatation of the ascending aorta (HP:0005111) | 2.34769661 |
| 50 | Vascular tortuosity (HP:0004948) | 2.34518656 |
| 51 | Obstructive lung disease (HP:0006536) | 2.33841380 |
| 52 | Chronic obstructive pulmonary disease (HP:0006510) | 2.33841380 |
| 53 | Purpura (HP:0000979) | 2.32677889 |
| 54 | Wormian bones (HP:0002645) | 2.32408286 |
| 55 | Autoimmune thrombocytopenia (HP:0001973) | 2.31182878 |
| 56 | Prolonged bleeding time (HP:0003010) | 2.22076095 |
| 57 | Pulmonary artery stenosis (HP:0004415) | 2.21391602 |
| 58 | Myocardial infarction (HP:0001658) | 2.21006793 |
| 59 | Nonimmune hydrops fetalis (HP:0001790) | 2.20764831 |
| 60 | Abnormality of skeletal muscle fiber size (HP:0012084) | 2.15280487 |
| 61 | Abnormality of the lumbar spine (HP:0100712) | 2.14459744 |
| 62 | Reduced antithrombin III activity (HP:0001976) | 2.12861974 |
| 63 | Mucosal telangiectasiae (HP:0100579) | 2.10495787 |
| 64 | Increased cerebral lipofuscin (HP:0011813) | 2.09363918 |
| 65 | Reticulocytopenia (HP:0001896) | 2.08760897 |
| 66 | Cerebral aneurysm (HP:0004944) | 2.08173672 |
| 67 | Recurrent fungal infections (HP:0002841) | 2.07792166 |
| 68 | Ankle contracture (HP:0006466) | 2.04782504 |
| 69 | Short middle phalanx of the 5th finger (HP:0004220) | 2.04488707 |
| 70 | Abnormality of iron homeostasis (HP:0011031) | 2.04276044 |
| 71 | Joint stiffness (HP:0001387) | 2.04178712 |
| 72 | Dysostosis multiplex (HP:0000943) | 2.03474789 |
| 73 | Abnormal platelet volume (HP:0011876) | 2.02974365 |
| 74 | Exertional dyspnea (HP:0002875) | 2.02860717 |
| 75 | Blue sclerae (HP:0000592) | 2.01140105 |
| 76 | Abnormal hemoglobin (HP:0011902) | 2.00041742 |
| 77 | Joint swelling (HP:0001386) | 1.99887607 |
| 78 | Nausea (HP:0002018) | 1.97638359 |
| 79 | Gingivitis (HP:0000230) | 1.97293251 |
| 80 | Increased density of long bones (HP:0006392) | 1.97278724 |
| 81 | Aplasia/Hypoplasia involving the sinuses (HP:0009120) | 1.96694484 |
| 82 | Poor head control (HP:0002421) | 1.95917648 |
| 83 | Basal ganglia calcification (HP:0002135) | 1.95278435 |
| 84 | Recurrent pneumonia (HP:0006532) | 1.94621369 |
| 85 | Aplastic anemia (HP:0001915) | 1.93955986 |
| 86 | Acanthocytosis (HP:0001927) | 1.93792492 |
| 87 | Osteomyelitis (HP:0002754) | 1.93522115 |
| 88 | Spinal rigidity (HP:0003306) | 1.93185800 |
| 89 | Spontaneous hematomas (HP:0007420) | 1.92573749 |
| 90 | Hematochezia (HP:0002573) | 1.91754065 |
| 91 | Polycythemia (HP:0001901) | 1.91259937 |
| 92 | Broad face (HP:0000283) | 1.90442933 |
| 93 | Optic neuritis (HP:0100653) | 1.90361968 |
| 94 | Retrobulbar optic neuritis (HP:0100654) | 1.90361968 |
| 95 | Periodontitis (HP:0000704) | 1.89652551 |
| 96 | Thoracolumbar scoliosis (HP:0002944) | 1.89229449 |
| 97 | Increased mean platelet volume (HP:0011877) | 1.87719897 |
| 98 | Abnormality of the acetabulum (HP:0003170) | 1.86932587 |
| 99 | Generalized aminoaciduria (HP:0002909) | 1.85614567 |
| 100 | Abnormality of lateral ventricle (HP:0030047) | 1.85566162 |
| 101 | Abnormality of T cell number (HP:0011839) | 1.85473162 |
| 102 | Delayed cranial suture closure (HP:0000270) | 1.85335914 |
| 103 | Arterial tortuosity (HP:0005116) | 1.82755415 |
| 104 | Recurrent lower respiratory tract infections (HP:0002783) | 1.82147739 |
| 105 | Interstitial pulmonary disease (HP:0006530) | 1.81259301 |
| 106 | Epistaxis (HP:0000421) | 1.81074194 |
| 107 | Aplasia/Hypoplasia of the frontal sinuses (HP:0009119) | 1.80843401 |
| 108 | Delayed closure of the anterior fontanelle (HP:0001476) | 1.80117254 |
| 109 | Patchy hypopigmentation of hair (HP:0011365) | 1.79504658 |
| 110 | Atrophic scars (HP:0001075) | 1.79147960 |
| 111 | Urticaria (HP:0001025) | 1.79091761 |
| 112 | Granulocytopenia (HP:0001913) | 1.79040331 |
| 113 | 3-Methylglutaconic aciduria (HP:0003535) | 1.78735935 |
| 114 | Eosinophilia (HP:0001880) | 1.78267953 |
| 115 | Tinnitus (HP:0000360) | 1.78076485 |
| 116 | Abnormality of dentin (HP:0010299) | 1.77922546 |
| 117 | Increased variability in muscle fiber diameter (HP:0003557) | 1.77772507 |
| 118 | Prostate neoplasm (HP:0100787) | 1.77603368 |
| 119 | Leukocytosis (HP:0001974) | 1.77485432 |
| 120 | Abnormality of glycolipid metabolism (HP:0010969) | 1.76467342 |
| 121 | Abnormality of liposaccharide metabolism (HP:0010968) | 1.76467342 |
| 122 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 1.76467342 |
| 123 | Axonal loss (HP:0003447) | 1.76241435 |
| 124 | Mitral stenosis (HP:0001718) | 1.76020101 |
| 125 | Systemic lupus erythematosus (HP:0002725) | 1.75255481 |
| 126 | Pathologic fracture (HP:0002756) | 1.75025091 |
| 127 | Renal Fanconi syndrome (HP:0001994) | 1.74474803 |
| 128 | White forelock (HP:0002211) | 1.74185636 |
| 129 | Hypergammaglobulinemia (HP:0010702) | 1.73054058 |
| 130 | Mucopolysacchariduria (HP:0008155) | 1.72424785 |
| 131 | Urinary glycosaminoglycan excretion (HP:0003541) | 1.72424785 |
| 132 | Vasculitis (HP:0002633) | 1.71809315 |
| 133 | Acute myeloid leukemia (HP:0004808) | 1.70717566 |
| 134 | Arterial thrombosis (HP:0004420) | 1.70591107 |
| 135 | Bruising susceptibility (HP:0000978) | 1.69867612 |
| 136 | Abnormal auditory evoked potentials (HP:0006958) | 1.69487607 |
| 137 | Distal lower limb amyotrophy (HP:0008944) | 1.69418692 |
| 138 | Reduced subcutaneous adipose tissue (HP:0003758) | 1.69364443 |
| 139 | Abnormality of transition element cation homeostasis (HP:0011030) | 1.68487593 |
| 140 | Abnormality of the pericardium (HP:0001697) | 1.68201998 |
| 141 | Increased serum ferritin (HP:0003281) | 1.68039596 |
| 142 | Type I transferrin isoform profile (HP:0003642) | 1.66667601 |
| 143 | Recurrent viral infections (HP:0004429) | 1.66237674 |
| 144 | Upper limb muscle weakness (HP:0003484) | 1.65662402 |
| 145 | Aortic valve stenosis (HP:0001650) | 1.65660761 |
| 146 | T lymphocytopenia (HP:0005403) | 1.65338310 |
| 147 | Abnormality of skull ossification (HP:0002703) | 1.65218746 |
| 148 | Slender build (HP:0001533) | 1.64023954 |
| 149 | Distal lower limb muscle weakness (HP:0009053) | 1.63455587 |
| 150 | Abnormality of the prostate (HP:0008775) | 1.58667202 |
| 151 | Episodic fever (HP:0001954) | 1.58488989 |
| 152 | Cardiovascular calcification (HP:0011915) | 1.55142592 |
| 153 | Abnormal delivery (HP:0001787) | 1.54777386 |
| 154 | Fragile skin (HP:0001030) | 1.52916450 |
| 155 | Cerebral hemorrhage (HP:0001342) | 1.50247970 |
| 156 | Amaurosis fugax (HP:0100576) | 1.49852244 |
| 157 | Type 1 muscle fiber predominance (HP:0003803) | 1.47401721 |
| 158 | Neoplasm of the rectum (HP:0100743) | 1.46598182 |
| 159 | Nemaline bodies (HP:0003798) | 1.45575807 |
| 160 | Chest pain (HP:0100749) | 1.45085308 |
| 161 | Encephalitis (HP:0002383) | 1.44964959 |
| 162 | Joint hemorrhage (HP:0005261) | 1.42802808 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | NME2 | 3.59639546 |
| 2 | PIM2 | 3.30093139 |
| 3 | KDR | 2.52940858 |
| 4 | MYLK | 2.41337319 |
| 5 | TESK1 | 2.39115218 |
| 6 | BMX | 2.37170097 |
| 7 | BLK | 2.30877335 |
| 8 | KIT | 2.27831342 |
| 9 | TGFBR2 | 2.18130763 |
| 10 | TESK2 | 2.08005703 |
| 11 | TEC | 2.07800101 |
| 12 | TRPM7 | 2.01818240 |
| 13 | IRAK4 | 1.94146580 |
| 14 | NEK9 | 1.93636987 |
| 15 | LIMK1 | 1.92366152 |
| 16 | GRK5 | 1.89216328 |
| 17 | JAK3 | 1.79007808 |
| 18 | MAP3K14 | 1.71840948 |
| 19 | MAP4K1 | 1.70950016 |
| 20 | TBK1 | 1.68190472 |
| 21 | TYK2 | 1.55912766 |
| 22 | ERN1 | 1.52404799 |
| 23 | LRRK2 | 1.50815765 |
| 24 | PBK | 1.47943565 |
| 25 | TGFBR1 | 1.45113529 |
| 26 | TXK | 1.44661217 |
| 27 | PIK3CG | 1.44391157 |
| 28 | MAP2K3 | 1.42277571 |
| 29 | EIF2AK1 | 1.40195434 |
| 30 | BMPR2 | 1.39433776 |
| 31 | STK10 | 1.37686971 |
| 32 | ZAP70 | 1.36439049 |
| 33 | BTK | 1.36100051 |
| 34 | IKBKB | 1.32543148 |
| 35 | IRAK3 | 1.32179807 |
| 36 | ERBB3 | 1.30415755 |
| 37 | MAPKAPK3 | 1.30381330 |
| 38 | RPS6KA4 | 1.28805834 |
| 39 | FES | 1.27896849 |
| 40 | EIF2AK3 | 1.27428908 |
| 41 | GRK6 | 1.27083855 |
| 42 | TIE1 | 1.25811359 |
| 43 | ACVR1B | 1.24390421 |
| 44 | GRK7 | 1.23832098 |
| 45 | PIK3CA | 1.17246878 |
| 46 | MAP3K12 | 1.15170984 |
| 47 | TAOK2 | 1.12793092 |
| 48 | TTN | 1.07522902 |
| 49 | IKBKE | 1.05773569 |
| 50 | ILK | 1.05229803 |
| 51 | PAK4 | 1.04970707 |
| 52 | FLT3 | 1.03345379 |
| 53 | MAPKAPK5 | 1.02620836 |
| 54 | ADRBK1 | 1.01022878 |
| 55 | PIM1 | 0.99495299 |
| 56 | CSF1R | 0.99283755 |
| 57 | VRK2 | 0.99103161 |
| 58 | EIF2AK2 | 0.99053317 |
| 59 | PAK2 | 0.99051957 |
| 60 | MOS | 0.97622900 |
| 61 | ZAK | 0.96277901 |
| 62 | EPHA3 | 0.96210132 |
| 63 | MST4 | 0.93598234 |
| 64 | MAP3K3 | 0.91641663 |
| 65 | STK16 | 0.88383125 |
| 66 | PLK2 | 0.88120324 |
| 67 | ARAF | 0.87121017 |
| 68 | LYN | 0.82292894 |
| 69 | ABL2 | 0.81968581 |
| 70 | FGR | 0.81902481 |
| 71 | MAP3K11 | 0.78328201 |
| 72 | MATK | 0.77871732 |
| 73 | SCYL2 | 0.77255016 |
| 74 | PTK2B | 0.76151581 |
| 75 | BMPR1B | 0.75556846 |
| 76 | LCK | 0.73672852 |
| 77 | NUAK1 | 0.72347880 |
| 78 | HCK | 0.71782511 |
| 79 | BUB1 | 0.70485029 |
| 80 | RPS6KB2 | 0.70359161 |
| 81 | LMTK2 | 0.70254810 |
| 82 | VRK1 | 0.70213335 |
| 83 | STK4 | 0.70143529 |
| 84 | MAPKAPK2 | 0.69577100 |
| 85 | PRKG2 | 0.69492223 |
| 86 | CLK1 | 0.68502551 |
| 87 | CDK8 | 0.68407693 |
| 88 | MKNK1 | 0.68327261 |
| 89 | NLK | 0.67163061 |
| 90 | JAK1 | 0.66918000 |
| 91 | DMPK | 0.66243001 |
| 92 | SYK | 0.64554182 |
| 93 | DAPK3 | 0.63727489 |
| 94 | CSK | 0.61541917 |
| 95 | RIPK4 | 0.60244028 |
| 96 | ITK | 0.60229065 |
| 97 | EPHB2 | 0.59509898 |
| 98 | TAOK3 | 0.59187961 |
| 99 | DAPK1 | 0.59067469 |
| 100 | BCKDK | 0.58357154 |
| 101 | CHUK | 0.58129835 |
| 102 | CDK6 | 0.57633647 |
| 103 | ROCK1 | 0.55181604 |
| 104 | PRKD1 | 0.53767005 |
| 105 | EPHB1 | 0.49840206 |
| 106 | PDGFRB | 0.49561836 |
| 107 | STK24 | 0.49474795 |
| 108 | IGF1R | 0.48502288 |
| 109 | TRIB3 | 0.47469789 |
| 110 | PAK1 | 0.46881349 |
| 111 | PTK2 | 0.46003749 |
| 112 | MAP3K8 | 0.45997018 |
| 113 | FER | 0.45837938 |
| 114 | ADRBK2 | 0.45619826 |
| 115 | DDR2 | 0.45405319 |
| 116 | PRKCD | 0.44899562 |
| 117 | PDGFRA | 0.44451126 |
| 118 | PRKCQ | 0.41912626 |
| 119 | IRAK1 | 0.41324948 |
| 120 | CDK7 | 0.41217198 |
| 121 | ABL1 | 0.40800056 |
| 122 | MAP3K5 | 0.39662569 |
| 123 | SIK3 | 0.39111975 |
| 124 | WEE1 | 0.38882060 |
| 125 | YES1 | 0.38341887 |
| 126 | STK3 | 0.37505496 |
| 127 | MARK3 | 0.37170780 |
| 128 | PLK3 | 0.35033537 |
| 129 | BRSK2 | 0.34758108 |
| 130 | CAMKK2 | 0.32203374 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Leishmaniasis_Homo sapiens_hsa05140 | 2.45279986 |
| 2 | Ribosome_Homo sapiens_hsa03010 | 2.32224134 |
| 3 | Malaria_Homo sapiens_hsa05144 | 2.23255722 |
| 4 | Sulfur metabolism_Homo sapiens_hsa00920 | 2.12416662 |
| 5 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 2.02250149 |
| 6 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 1.93723620 |
| 7 | DNA replication_Homo sapiens_hsa03030 | 1.81470431 |
| 8 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 1.80307417 |
| 9 | Shigellosis_Homo sapiens_hsa05131 | 1.77461750 |
| 10 | Proteasome_Homo sapiens_hsa03050 | 1.76288845 |
| 11 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.75327368 |
| 12 | Legionellosis_Homo sapiens_hsa05134 | 1.73649027 |
| 13 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.68771818 |
| 14 | Measles_Homo sapiens_hsa05162 | 1.67013225 |
| 15 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.61634839 |
| 16 | Pertussis_Homo sapiens_hsa05133 | 1.61445922 |
| 17 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 1.61214451 |
| 18 | Other glycan degradation_Homo sapiens_hsa00511 | 1.57276045 |
| 19 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.56986493 |
| 20 | Allograft rejection_Homo sapiens_hsa05330 | 1.56085021 |
| 21 | Viral myocarditis_Homo sapiens_hsa05416 | 1.51951257 |
| 22 | Osteoclast differentiation_Homo sapiens_hsa04380 | 1.50127524 |
| 23 | Protein export_Homo sapiens_hsa03060 | 1.48283638 |
| 24 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 1.47109251 |
| 25 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 1.46643332 |
| 26 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.45937965 |
| 27 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 1.45608877 |
| 28 | Apoptosis_Homo sapiens_hsa04210 | 1.43645028 |
| 29 | Phagosome_Homo sapiens_hsa04145 | 1.41320975 |
| 30 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 1.40822715 |
| 31 | p53 signaling pathway_Homo sapiens_hsa04115 | 1.40061819 |
| 32 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 1.39683382 |
| 33 | ECM-receptor interaction_Homo sapiens_hsa04512 | 1.38840215 |
| 34 | Graft-versus-host disease_Homo sapiens_hsa05332 | 1.36525465 |
| 35 | Salmonella infection_Homo sapiens_hsa05132 | 1.34356101 |
| 36 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.33741061 |
| 37 | Asthma_Homo sapiens_hsa05310 | 1.32323279 |
| 38 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 1.27524192 |
| 39 | Lysosome_Homo sapiens_hsa04142 | 1.27053590 |
| 40 | Base excision repair_Homo sapiens_hsa03410 | 1.26958365 |
| 41 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.26765131 |
| 42 | Tuberculosis_Homo sapiens_hsa05152 | 1.26690812 |
| 43 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.26097785 |
| 44 | Endocytosis_Homo sapiens_hsa04144 | 1.24177920 |
| 45 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 1.21695161 |
| 46 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.19506270 |
| 47 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.16178905 |
| 48 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.14200071 |
| 49 | Focal adhesion_Homo sapiens_hsa04510 | 1.12986392 |
| 50 | Hepatitis B_Homo sapiens_hsa05161 | 1.12392630 |
| 51 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.11641588 |
| 52 | Homologous recombination_Homo sapiens_hsa03440 | 1.09007284 |
| 53 | Platelet activation_Homo sapiens_hsa04611 | 1.08331696 |
| 54 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 1.07796915 |
| 55 | Small cell lung cancer_Homo sapiens_hsa05222 | 1.07218293 |
| 56 | Influenza A_Homo sapiens_hsa05164 | 1.05808258 |
| 57 | Mismatch repair_Homo sapiens_hsa03430 | 1.05340843 |
| 58 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 1.04788375 |
| 59 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.03363269 |
| 60 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.99670015 |
| 61 | Nucleotide excision repair_Homo sapiens_hsa03420 | 0.96355083 |
| 62 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.95357224 |
| 63 | Amoebiasis_Homo sapiens_hsa05146 | 0.93238695 |
| 64 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.90259332 |
| 65 | Primary immunodeficiency_Homo sapiens_hsa05340 | 0.88152999 |
| 66 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 0.87367761 |
| 67 | Cell cycle_Homo sapiens_hsa04110 | 0.87048085 |
| 68 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 0.86632871 |
| 69 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.85840417 |
| 70 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 0.84930933 |
| 71 | Non-homologous end-joining_Homo sapiens_hsa03450 | 0.84861857 |
| 72 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.84719353 |
| 73 | Adherens junction_Homo sapiens_hsa04520 | 0.84301231 |
| 74 | Gap junction_Homo sapiens_hsa04540 | 0.81816844 |
| 75 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.81777022 |
| 76 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.79847520 |
| 77 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.79596608 |
| 78 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.79310706 |
| 79 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.77801004 |
| 80 | TGF-beta signaling pathway_Homo sapiens_hsa04350 | 0.77768647 |
| 81 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 0.77672494 |
| 82 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.77363750 |
| 83 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.76937232 |
| 84 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.76604423 |
| 85 | Nitrogen metabolism_Homo sapiens_hsa00910 | 0.76377668 |
| 86 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.74682997 |
| 87 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.73980000 |
| 88 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.73324704 |
| 89 | PI3K-Akt signaling pathway_Homo sapiens_hsa04151 | 0.73086220 |
| 90 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.71714381 |
| 91 | HTLV-I infection_Homo sapiens_hsa05166 | 0.71512699 |
| 92 | RNA polymerase_Homo sapiens_hsa03020 | 0.71166589 |
| 93 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.70328593 |
| 94 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.69478017 |
| 95 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.69357274 |
| 96 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.68536782 |
| 97 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 0.64406872 |
| 98 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.64029023 |
| 99 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.60758641 |
| 100 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 0.60525366 |
| 101 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.57278291 |
| 102 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.56667342 |
| 103 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.56296332 |
| 104 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.55102674 |
| 105 | Hepatitis C_Homo sapiens_hsa05160 | 0.54817769 |
| 106 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.54457033 |
| 107 | Pathways in cancer_Homo sapiens_hsa05200 | 0.54082839 |
| 108 | Thyroid cancer_Homo sapiens_hsa05216 | 0.53293688 |
| 109 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.52759103 |
| 110 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 0.52642386 |
| 111 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.52359269 |
| 112 | Spliceosome_Homo sapiens_hsa03040 | 0.51854940 |
| 113 | Parkinsons disease_Homo sapiens_hsa05012 | 0.49354014 |
| 114 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.49113459 |
| 115 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.48072837 |
| 116 | Purine metabolism_Homo sapiens_hsa00230 | 0.47760557 |
| 117 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 0.47204361 |
| 118 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.46435374 |
| 119 | Melanoma_Homo sapiens_hsa05218 | 0.46415354 |
| 120 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.44510362 |
| 121 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.43769714 |
| 122 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.43721730 |
| 123 | Serotonergic synapse_Homo sapiens_hsa04726 | 0.42375479 |
| 124 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.40474781 |
| 125 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.40010531 |
| 126 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.36684508 |
| 127 | Galactose metabolism_Homo sapiens_hsa00052 | 0.36613858 |

